Gestational diabetes & diabetes in pregnancy

A mobile phone application for the prevention of type 2 diabetes in Malaysian women with gestational diabetes mellitus ( MYGODDESS ): A feasibility randomised controlled trial

Diabet MedPublished Feasibility randomised controlled trial

Authors' conclusion

The participation rate was in keeping with previous DPI trials and the attrition rate was low, suggesting it is feasible to conduct a full-scale RCT.

Study context

Population
Malaysian women with gestational diabetes mellitus (GDM), randomised at ≈30 weeks' gestation660 screened
Participants
60 women
Comparison
Mobile app-based diabetes prevention intervention plus usual GDM care vs usual GDM care
Primary endpoint
Feasibility: proportion of women who consented, were eligible and randomised and provided outcome data
Methodological detailstwo-arm, parallel
  • Two-arm
  • Parallel

Primary result

As reported in the abstract

Recruitment and retention

Consented for eligibility screening (of 660 screened)

294

45%

Eligible

164

24.9%

Consented and randomised

60

9%

Completed biomedical outcomes at each follow-up

85%

Secondary outcomes

Biomedical and secondary outcomes · 36 weeks' gestation, 3 and 6 months postpartum

No treatment effect on any other biomedical outcomes or secondary outcomes

Original publication

A mobile phone application for the prevention of type 2 diabetes in Malaysian women with gestational diabetes mellitus ( MYGODDESS ): A feasibility randomised controlled trial. Diabet Med. Published 10 March 2026. doi:10.1111/dme.70257

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.